Immune-checkpoint inhibitors in pituitary malignancies.

MLA

Di Nunno, Vincenzo, et al. “Immune-Checkpoint Inhibitors in Pituitary Malignancies.” Anti-Cancer Drugs, vol. 33, no. 1, Jan. 2022, pp. e28–35. EBSCOhost, https://doi.org/10.1097/CAD.0000000000001157.

APA

Di Nunno, V., Franceschi, E., Tosoni, A., Gatto, L., Maggio, I., Lodi, R., Bartolini, S., & Brandes, A. A. (2022). Immune-checkpoint inhibitors in pituitary malignancies. Anti-Cancer Drugs, 33(1), e28–e35. https://doi.org/10.1097/CAD.0000000000001157

Chicago

Di Nunno, Vincenzo, Enrico Franceschi, Alicia Tosoni, Lidia Gatto, Ilaria Maggio, Raffaele Lodi, Stefania Bartolini, and Alba A Brandes. 2022. “Immune-Checkpoint Inhibitors in Pituitary Malignancies.” Anti-Cancer Drugs 33 (1): e28–35. doi:10.1097/CAD.0000000000001157.